Patent · US Active

c-Myc mRNA translation modulators and uses thereof in the treatment of cancer

US12344600B2 · kind B2 · utility

0Cited by
4References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2023
Grant dateJul 1, 2025
Priority date
Expiry dateMar 15, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel c-Myc mRNA translation modulators, composition and methods of preparation CA thereof, and uses thereof in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.